AMN Healthcare Services (AMN) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $741 million, down 25% year-over-year and 10% sequentially, with net income of $16.2 million and adjusted EPS of $0.98, both significantly lower than last year.

• Adjusted EBITDA was $94 million, with a margin of 12.7%, exceeding guidance due to favorable actuarial adjustments and lower employee expenses.

• Operating cash flow was $100 million in Q2, with $80 million in debt reduction and cash and equivalents at $48 million.

• The business is stabilizing amid challenging market conditions, with demand for healthcare and skilled caregivers showing improvement, though client utilization of contingent labor remains pressured.

• Technology and Workforce Solutions contributed 41% of operating income, with language services revenue up 18% year-over-year.

Financial highlights

• Gross margin for Q2 was 31.0%, down 230 basis points year-over-year and 40 basis points sequentially, mainly due to lower margins in nurse and allied and technology segments.

• Adjusted earnings per share was $0.98, compared to $2.38 in the prior year and $0.97 in the prior quarter; diluted EPS was $0.42, down from $1.55 last year.

• SG&A expenses for Q2 were $149 million (20.1% of revenue), down from $202 million (20.4%) last year.

• Days Sales Outstanding was 63 at quarter end, 1 day lower than the prior quarter but 10 days higher year-over-year.

• CapEx for the quarter was $27 million; full-year CapEx expected at $70-$75 million.

Outlook and guidance

• Q3 2024 consolidated revenue projected at $660–$680 million, down 20–23% year-over-year.

• Gross margin expected between 30.7%–31.2%; operating margin 2.1%–2.9%; adjusted EBITDA margin 10.6%–11.1%.

• Nurse and Allied revenue for Q3 expected to be down 32%–34% year-over-year; Physician and Leadership Solutions up 12%–14%; Technology and Workforce Solutions down 10%–12%.

• Management expects an annual effective tax rate of approximately 28% for 2024.

• Cash from operations and available credit are expected to be sufficient for liquidity needs over the next 12 months and beyond.